Evidence map›Paper›PMID 23270585›Full record

ArticleLeukemia & lymphoma2013

Correlation of Fc-γ RIIA polymorphisms with latent Epstein-Barr virus infection and latent membrane protein 1 expression in patients with low grade B-cell lymphomas.

Panagiotis T Diamantopoulos, Vassiliki Kalotychou, Katerina Polonyfi, Maria Sofotasiou, Amalia Anastasopoulou, Athanassios Galanopoulos, Nikolaos Spanakis, Theodoros Vassilakopoulos, Maria Angelopoulou, Maria Siakantaris and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia & lymphoma, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Fcγ Receptors in Solid Organ Transplantation.Current transplantation reports · 2016
    Review
  7. Review
  8. Review
  9. Review
  10. Human FcR polymorphism and disease.Current topics in microbiology and immunology · 2014
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Panagiotis T Diamantopoulos1st Department of Internal Medicine, Hematology Unit, Laikon General Hospital, National and Kapodistrian University of Athens, Greece. pandiamantopoulos@gmail.com
Vassiliki Kalotychou
Katerina Polonyfi
Maria Sofotasiou
Amalia Anastasopoulou
Athanassios Galanopoulos
Nikolaos Spanakis
Theodoros Vassilakopoulos
Maria Angelopoulou
Maria Siakantaris
Eleni Variami
Christos Poziopoulos
Evangelos Terpos
Panagoula Kollia
Nora-Athina Viniou
Laiko General Hospital of Athens · GRNational and Kapodistrian University of Athens · GRGeneral Hospital of Athens G. Genimatas · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fc-γ RIIA (CD32), a member of the family of Fc-γ receptors, participates in the phagocytosis of bound to antibody antigens. The effectiveness of this function varies for its several haplotypes, and it participates in the pathogenesis of viral infections, according to recent studies. The genetic locus of Fc-γ RIIA consists of two allelic genes: 131-Arg (R131) and 131-His (H131). Our aim was to correlate Fc-γ RIIA polymorphisms, by studying the prevalence of each allele using PCR-RFLPs (polymerase chain reaction-restriction fragment length polymorphisms), with latent Epstein-Barr virus (EBV) infection and the expression of latent membrane protein 1 (LMP1) in 40 patients with leukemic low grade B-cell lymphomas. R131 was found in 84.2% of EBV-positive patients, but only in 28.5% of EBV-negative patients (p = 0.001). A similar correlation was found for R131 and LMP1 expression (84.6% vs. 28.5%) (p = 0.002). Our results support the hypothesis that Fc-γ RIIA polymorphisms are a genetic risk factor for latent EBV infection and the expression of its oncogenic latency proteins.

Indexed as

Gene ExpressionPolymorphism, GeneticAgedAged, 80 and overAllelesFemaleGenotypeHumansLymphoma, B-CellMaleMiddle AgedNeoplasm GradingReceptors, IgGViral Matrix ProteinsEBV-associated membrane antigen, Epstein-Barr virusFc gamma receptor IIAReceptors, IgGViral Matrix Proteins

Identifiers

PMID23270585
OpenAlexW2169722887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.